PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy.
Lidija AntunovicRita De SanctisLuca CozziMargarita KirienkoAndrea SagonaRosalba TorrisiCorrado TinterriArmando SantoroArturo ChitiRenata ZelicMartina SolliniPublished in: European journal of nuclear medicine and molecular imaging (2019)
Our models predicted that patients with subtype 2 and subtype 3 (HER2+ and triple negative, respectively) are more likely to have a pCR to NAC than those with subtype 1 (luminal). The association between PET imaging features and pCR suggested that PET imaging features could be considered as potential predictors of pCR in locally advanced breast cancer patients.
Keyphrases
- pet imaging
- neoadjuvant chemotherapy
- locally advanced
- pet ct
- positron emission tomography
- rectal cancer
- squamous cell carcinoma
- lymph node
- sentinel lymph node
- radiation therapy
- computed tomography
- phase ii study
- real time pcr
- transcription factor
- lymph node metastasis
- early stage
- climate change
- magnetic resonance imaging
- magnetic resonance
- study protocol
- open label
- breast cancer risk